National Bank of Canada FI Has $61.76 Million Stake in Humana Inc. (NYSE:HUM)

National Bank of Canada FI increased its stake in shares of Humana Inc. (NYSE:HUM - Free Report) by 93.7% during the 4th quarter, according to its most recent filing with the SEC. The institutional investor owned 131,371 shares of the insurance provider's stock after acquiring an additional 63,545 shares during the period. National Bank of Canada FI owned approximately 0.11% of Humana worth $61,757,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. Rakuten Securities Inc. acquired a new stake in shares of Humana during the fourth quarter worth approximately $25,000. Gradient Investments LLC raised its stake in shares of Humana by 200.0% in the 4th quarter. Gradient Investments LLC now owns 60 shares of the insurance provider's stock valued at $27,000 after purchasing an additional 40 shares in the last quarter. Cetera Trust Company N.A acquired a new stake in shares of Humana in the 4th quarter valued at about $28,000. Nvwm LLC lifted its position in shares of Humana by 41.0% during the third quarter. Nvwm LLC now owns 86 shares of the insurance provider's stock worth $42,000 after purchasing an additional 25 shares during the last quarter. Finally, Turtle Creek Wealth Advisors LLC acquired a new position in Humana in the fourth quarter worth about $55,000. Hedge funds and other institutional investors own 92.38% of the company's stock.

Insider Buying and Selling

In other Humana news, Director Jorge S. Mesquita purchased 545 shares of the business's stock in a transaction on Tuesday, February 20th. The stock was bought at an average cost of $367.09 per share, with a total value of $200,064.05. Following the acquisition, the director now owns 2,578 shares of the company's stock, valued at $946,358.02. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. 0.32% of the stock is owned by corporate insiders.

Analyst Upgrades and Downgrades

Several brokerages have recently commented on HUM. Mizuho decreased their target price on Humana from $550.00 to $400.00 and set a "buy" rating for the company in a research report on Friday, January 26th. StockNews.com lowered shares of Humana from a "strong-buy" rating to a "hold" rating in a research note on Friday, January 26th. Barclays reduced their price target on shares of Humana from $356.00 to $310.00 and set an "equal weight" rating on the stock in a research report on Tuesday, April 2nd. Oppenheimer lowered their price objective on shares of Humana from $415.00 to $370.00 and set an "outperform" rating for the company in a research report on Thursday, April 25th. Finally, Wells Fargo & Company cut their target price on shares of Humana from $413.00 to $350.00 and set an "overweight" rating on the stock in a report on Monday, April 8th. Eleven equities research analysts have rated the stock with a hold rating and nine have given a buy rating to the company's stock. Based on data from MarketBeat.com, the stock currently has an average rating of "Hold" and a consensus price target of $424.50.

Humana Price Performance

Humana stock traded down $0.44 during trading hours on Friday, hitting $320.54. 1,802,675 shares of the company traded hands, compared to its average volume of 1,607,966. The firm's 50-day simple moving average is $324.12 and its two-hundred day simple moving average is $387.61. The firm has a market cap of $38.63 billion, a P/E ratio of 19.96, a P/E/G ratio of 1.86 and a beta of 0.49. Humana Inc. has a 1-year low of $298.61 and a 1-year high of $541.21. The company has a quick ratio of 1.67, a current ratio of 1.67 and a debt-to-equity ratio of 0.77.

Humana (NYSE:HUM - Get Free Report) last posted its quarterly earnings data on Wednesday, April 24th. The insurance provider reported $7.23 EPS for the quarter, beating analysts' consensus estimates of $6.12 by $1.11. The business had revenue of $29.61 billion for the quarter, compared to analyst estimates of $28.52 billion. Humana had a net margin of 1.82% and a return on equity of 17.76%. The business's revenue for the quarter was up 10.7% on a year-over-year basis. During the same quarter last year, the business earned $9.38 earnings per share. As a group, analysts forecast that Humana Inc. will post 16.18 earnings per share for the current fiscal year.

Humana Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, July 26th. Investors of record on Friday, June 28th will be paid a dividend of $0.885 per share. The ex-dividend date of this dividend is Friday, June 28th. This represents a $3.54 annualized dividend and a yield of 1.10%. Humana's dividend payout ratio is currently 22.04%.

Humana Company Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.